Corso FAD

“Il Long-COVID: un nuovo scenario clinico”

Bibliografia

 American Thoracic Society. ATS Statement: Guidelines for the Six-Minutes Walk
Test. Am J Respir Crit Care Med 2002; 166:111-117

 Andersen ML, Tufik S. The Association Between Sleep Disturbances and Erectile
Dysfunction During the COVID-19 Pandemic. Sex Med Rev. 2022 Apr;10(2):263-
270. doi: 10.1016/j.sxmr.2021.12.001. Epub 2021 Dec 17. PMID: 35042659;
PMCID: PMC8677465.

 Asadi-Pooya AA, Akbari A, Emami A, Lotfi M, Rostamihosseinkhani M, Nemati H,

Barzegar Z, Kabiri M, Zeraatpisheh Z, Farjoud-Kouhanjani M, Jafari A, Sasannia S,
Ashrafi S, Nazeri M, Nasiri S, Shahisavandi M. Long COVID syndrome-associated
brain fog. J Med Virol. 2022 Mar;94(3):979-984. doi: 10.1002/jmv.27404. Epub
2021 Oct 24. PMID: 34672377; PMCID: PMC8662118.

 Attal N, et al. Potential for increased prevalence of neuropathic pain after the
COVID-19 pandemic. Pain Rep 2021;6:e884.

 Ayoubkhani D, Khunti K, Nafilyan V, et al. Post-covid syndrome in individuals

admitted to hospital with covid-19: retrospective cohort study. BMJ 2022;372:n693

 Bohannon RW, Crouch R et al. 1-Minute Sit-to-Stand Test: systematic review of

procedures, performance, and clinimetric properties. J Cardiopulm Rehab Prevent
2019;39:2-8

 Borel M., Luyu Xie L., Kapera O., Mihalcea A., Kahn J., Messiah S. E., Long term
physical, mental and social health efects of COVID 19 in the pediatric population: a
scoping review World J Pediatr. 2022 Mar;18(3):149-159

 Buoite Stella A, Furlanis G, Frezza NA, et al. Autonomic dysfunction in post-COVID

patients with and without neurological symptoms: a prospective multidomain
observational study. J Neurol 2022;269:587-596.

 Carfì A, Bernabei R, Landi F. Persistent symptoms in patients after COVID-19. JAMA

2020;324:603-605. doi: 10.1001/jama2020.12603

 Carmona-Torre F, Mínguez-Olaondo A, López-Bravo A, Tijero B, Grozeva V, Walcker

M, Azkune-Galparsoro H, López de Munain A, Alcaide AB, Quiroga J, Del Pozo JL,
Gómez-Esteban JC. Dysautonomia in COVID-19 Patients: A Narrative Review on
Clinical Course, Diagnostic and Therapeutic Strategies. Front Neurol. 2022 May

1
 Corso FAD
“Il Long-COVID: un nuovo scenario clinico”

27;13:886609. doi: 10.3389/fneur.2022.886609. PMID: 35720084; PMCID:

PMC9198643..

 Caronna E, Pozo-Rosich P. Headache as a Symptom of COVID-19: Narrative Review

of 1-Year Research. Curr Pain Headache Rep. 2021 Nov 11;25(11):73. doi:
10.1007/s11916-021-00987-8. PMID: 34766205; PMCID: PMC8583579.

 Caronna E, van den Hoek TC, Bolay H, Garcia-Azorin D, Gago-Veiga AB, Valeriani
M, Takizawa T, Messlinger K, Shapiro RE, Goadsby PJ, Ashina M, Tassorelli C,
Diener HC, Terwindt GM, Pozo-Rosich P. Headache attributed to SARS-CoV-2
infection, vaccination and the impact on primary headache disorders of the COVID-
19 pandemic: A comprehensive review. Cephalalgia. 2023
Jan;43(1):3331024221131337. doi: 10.1177/03331024221131337. PMID:
36606562.

 Ceban F, Ling S, Lui LMW, Lee Y, Gill H, Teopiz KM, Rodrigues NB, Subramaniapillai
M, Di Vincenzo JD, Cao B, Lin K, Mansur RB, Ho RC, Rosenblat JD, Miskowiak KW,
Vinberg M, Maletic V, McIntyre RS. Fatigue and cognitive impairment in Post-
COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behav Immun.
2022 Mar;101:93-135. doi: 10.1016/j.bbi.2021.12.020. Epub 2021 Dec 29. PMID:
34973396; PMCID: PMC8715665..

 Chasco EE, Dukes K, Jones D, Comellas AP, Hoffman RM, Garg A. Brain Fog and
Fatigue following COVID-19 Infection: An Exploratory Study of Patient Experiences
of Long COVID. Int J Environ Res Public Health. 2022 Nov 23;19(23):15499. doi:
10.3390/ijerph192315499. PMID: 36497573; PMCID: PMC9737348.

 Crook H, Raza S, Nowell J, Young M, Edison P. Long Covid – Mechanisms, risk

factors, and management. BMJ 2021;374:n1648. doi: 10.1136/bmj.n1648

 Davis He, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings,
mechanisms and recommendations. Nat Rev Microbiol 2023;21:133-146 doi:
10.1038/s41579-022-00846-2

 Eliaçik S, et al. Post-COVID 19 and Neuropathic Pain. J Infect Dis Epidemiol

2022;8:247

 Esposito S., Principi N., Azzari C., et al. Italian intersociety consensus on
management of long covid in children. Ital J Pediatr. 2022 Mar 9;48(1):42

2
 Corso FAD
“Il Long-COVID: un nuovo scenario clinico”

 European Society for Microbiology and Infectious Diseases. Yelin D, Moschopoulos

CD, Margalit I, et al. ESCMID rapid guidelines for assessment and management of
long COVID. Clin Microbiol Infect 2022; 28:955-972

 Floridia M, Grassi T, Giuliano M, Tiple D, Pricci F, Villa M, Silenzi A, Onder G.

Characteristics of Long-COVID care centers in Italy. A national survey of 124 clinical
sites. Front Public Health. 2022 Aug 19;10:975527. doi:
10.3389/fpubh.2022.975527. Accessibile a:
https://www.frontiersin.org/articles/10.3389/fpubh.2022.975527/full

 Freedberg DE, Chang L. Gastrointestinal symptoms in COVID-19: the long and the
short of it. Curr Opin Gastroenterol. 2022 Nov 1;38(6):555-561. doi:
10.1097/MOG.0000000000000876. Epub 2022 Sep 9. PMID: 36165028.

 Giuliano M, Tiple D, Agostoni P, Armocida B, Biardi L, Bonfigli AR, Campana A,

Ciardi M, Di Marco F, Floridia M, Gnerre P, Grassi T, Grattagliano I, Kruger P,
Leonardi M, Liguori R, Pagani E, Perger E, Pricci F, Ruggeri M, Silenzi A, Spannella
F, Tascini C, Teté G, Tosato M, Vecchi S, Villa M and Onder G (2023) Italian good
practice recommendations on management of persons with Long-COVID. Front.
Public Health 11:1122141. doi: 10.3389/fpubh.2023.112214

 Global Burden of Disease Long COVID Collaborators. Estimated global proportions

of individuals with persistent fatigue, cognitive, and respiratory symptom clusters
following symptomatic COVID-19 in 2020 and 2021. JAMA 2022;328:1604-1615

 Groff G, Sun A, Ssentongo AE, et al. Short-term and long-term rates of postacute
sequelae of SARS-CoV-2 infection: a systematic review. JAMA Netw Open
2021;4:e2128568

 Italia. D.L. 25 maggio 2021, n. 73 (1) (2). Misure urgenti connesse all'emergenza
da COVID-19, per le imprese, il lavoro, i giovani, la salute e i servizi territoriali. (1)
Pubblicato nella Gazz. Uff. 25 maggio 2021, n. 123. (2) Convertito in legge, con
modificazioni, dall’ art. 1, comma 1, L. 23 luglio 2021, n. 106. Accessibile a:
https://www.lavoro.gov.it/documenti-e-norme/normative/Documents/2021/DL-
25052021-n-73-Sostegni-bis.pdf

 Jennings G, et al. A systematic review of persistent symptoms and residual

abnormal functioning following acute COVID-19: ongoing symptomatic phase vs.
Post-COVID19 syndrome. J Clin Med 2021;10:5913

3
 Corso FAD
“Il Long-COVID: un nuovo scenario clinico”

 Khoja O, et al. Clinical Characteristics and Mechanisms of Musculoskeletal Pain in

Long COVID. J Pain Res 2022;15:1729-1748

 Mazza MG, Palladini M, Poletti S, Benedetti F. Post-COVID-19 Depressive

Symptoms: Epidemiology, Pathophysiology, and Pharmacological Treatment. CNS
Drugs. 2022 Jul;36(7):681-702. doi: 10.1007/s40263-022-00931-3. Epub 2022
Jun 21. PMID: 35727534; PMCID: PMC9210800.

 Michelen M, et al. Characterising long COVID: a living systematic review. BMJ Glob
Health. 2021 6:e005427

 Mills G, et al. The prevalence and location of musculoskeletal pain following COVID‐
19. Musculoskeletal Care 2022;May 23;10.1002

 Munblit D, et al. Incidence and risk factors for persistent symptoms in adults
previously hospitalized for COVID-19. Clin Exp Allergy 2021;51:1107-1120

 Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med

2021;27:601-615. doi: 10.1038/s41591-021-01283-z

 Narasimhan B, Calambur A, Moras E, Wu L, Aronow W. Postural Orthostatic

Tachycardia Syndrome in COVID-19: A Contemporary Review of Mechanisms,
Clinical Course and Management. Vasc Health Risk Manag. 2023 May 12;19:303-
316. doi: 10.2147/VHRM.S380270. PMID: 37204997; PMCID: PMC10187582.

 Oaklander AL, et al. Peripheral Neuropathy Evaluations of Patients With Prolonged

Long COVID. Neurol Neuroimmunol Neuroinflamm 2022;3:e1146

 Onder G, Floridia M, Giuliano M, Lo Noce C, Tiple D, Bertinato L, Mariniello R,

Laganà MG, Della Vecchia A, Gianferro R, De Feo A, Cosenza P, Di Corcia T,
Gianfranco Gensini G, Palummeri E, Frabetti C, Aliberti S, Campana A, Carfì A,
Landi F, Rossi A, Cherubini A, Uccelli A, Barisione E, Benedetti L, Bartoloni A,
Bonfanti P, Carlesimo M, Guaraldi G, Milic J, Leonardi S, Petrosillo N, Tarsia P.
Indicazioni ad interim sui principi di gestione del Long-COVID. Versione del 1° luglio
2021. Roma: Istituto Superiore di Sanità; 2021. (Rapporto ISS COVID-19 n.
15/2021) Accessibile a:
https://www.iss.it/documents/20126/0/Rapporto+ISS+COVID-
19+15_2021.pdf/a97f5be0-983b-efaa-2638-3cafc8380296?t=1625124332301

 Piva T, Masotti S, Raisi A, Zerbini V, Grazzi G, Mazzoni G, Belvederi Murri M,

Mandini S. Exercise program for the management of anxiety and depression in

4
 Corso FAD
“Il Long-COVID: un nuovo scenario clinico”

adults and elderly subjects: Is it applicable to patients with post-covid-19

condition? A systematic review and meta-analysis. J Affect Disord. 2023 Mar
15;325:273-281. doi: 10.1016/j.jad.2022.12.155. Epub 2023 Jan 10. PMID:
36634854; PMCID: PMC9829440.

 Premraj L, Kannapadi NV, Briggs J, Seal SM, Battaglini D, Fanning J, Suen J, Robba
C, Fraser J, Cho SM. Mid and long-term neurological and neuropsychiatric
manifestations of post-COVID-19 syndrome: A meta-analysis. J Neurol Sci. 2022
Mar 15;434:120162. doi: 10.1016/j.jns.2022.120162. Epub 2022 Jan 29. PMID:
35121209; PMCID: PMC8798975..

 Rizvi A, Ziv Y, Crawford JM, Trindade AJ. Gastrointestinal and Hepatobiliary

Symptoms and Disorders with Long (Chronic) COVID Infection. Gastroenterol Clin
North Am. 2023 Mar;52(1):139-156. doi: 10.1016/j.gtc.2022.09.002. PMID:
36813422; PMCID: PMC9940919.

 Shaik L, Boike S, Ramar K, Subramanian S, Surani S. COVID-19 and Sleep

Disturbances: A Literature Review of Clinical Evidence. Medicina (Kaunas). 2023
Apr 22;59(5):818. doi: 10.3390/medicina59050818. PMID: 37241050; PMCID:
PMC10221134.

 Shanthanna H, et al. The COVID-19 pandemic and its consequences for chronic
pain: a narrative review. Anaesthesia 2022;77:1039-1050.

 Sherif Z.A., Gomez C.R., Connors T.J., Henrich T.J., Reeves W.B. Pathogenic
mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC). Elife. 2023
Mar 22;12: e86002

 Sisó-Almirall A, et al. Long Covid-19: Proposed Primary Care Clinical Guidelines for
Diagnosis and Disease Management. Int J Environ Res Public Health. 2021;18:4350

 Stephenson T, Allin B, Nugawela M.D, Rojas N, Dalrymple E, Pinto Pereira S, Soni

M, Knight M, Cheung E. Y, Heyman I. Long COVID (post-COVID-19 condition) in
children: a modified Delphi process. Arch Dis Child. 2022 Jul;107(7):674-680

 Tana C, Bentivegna E, Cho SJ, Harriott AM, García-Azorín D, Labastida-Ramirez A,

Ornello R, Raffaelli B, Beltrán ER, Ruscheweyh R, Martelletti P. Long COVID
headache. J Headache Pain. 2022 Aug 1;23(1):93. doi: 10.1186/s10194-022-
01450-8. PMID: 35915417; PMCID: PMC9340759.

5
 Corso FAD
“Il Long-COVID: un nuovo scenario clinico”

 Tedjasukmana R, Budikayanti A, Islamiyah WR, Witjaksono AMAL, Hakim M. Sleep

disturbance in post COVID-19 conditions: Prevalence and quality of life. Front
Neurol. 2023 Jan 9;13:1095606. doi: 10.3389/fneur.2022.1095606. PMID:
36698905; PMCID: PMC9869804.